Biocon English news | Biocon, Latest News & Live Updates in English | English News (Latest English News) at Lokmattimes.com

"We will offer the anti-diabetic drug at 10 cents for 40 units of insulin required per patient per day in low-and-middle income countries," said the city-based bio-pharma firm in a statement here.Biocon chairperson Kiran Mazumdar-Shaw announced the reduction in the cost of life-saving insulin at the joint United Nations Progamme on HIV and AIDS (UNAIDS) health innovation exchange meeting on Wednesday on the margins of the UN General Assembly in New York."Price should not be the reason to choose between life and death," said UNAIDS executive director Gunilla Carlsson on the occasion.Over 400 million people worldwide are affected by diabetes. Evidence shows as they live longer, many people with HIV and on HIV treatment are becoming susceptible to non-communicable diseases."AIDS activism has led to reducing the price of life-saving medicines and saving millions of lives. Our universal health coverage movement is benefiting from the lessons learned by the AIDS response," said Carlsson on the occasion.The Mumbai-based Wadhwani Institute for Artificial Intelligence, an independent, non-profit research institute and global hub, is developing artificial intelligence solutions for social good."The Institute has committed to set up a centre of excellence to leverage the use of artificial intelligence for global health," said the statement.The IoT has opened up huge possibilities in health: when connected to the Internet, ordinary medical devices can collect more data, give insight into symptoms and trends, enable remote care and give people more control over their lives and quality of treatment.Thought-Focus, a technology services firm, will provide access to its Internet of Things (IoT) platform to serve as an affordable, reliable and efficient way to build and extend IoT solutions for transportation, logistics, manufacturing and utilities related to health-care services."The IoT has opened up huge possibilities in health. When connected to the Internet, ordinary medical devices can collect more data, give insight into symptoms and trends, enable remote care and give people control over their lives and quality of treatment," said the statement.Zenysis, a technology firm, said it was investing $ 3.5 million to implement data pilots in five countries over the next three years for helping countries to make evidence-based decisions in rolling out universal health coverage and prioritizing investments in health systems."The private sector has a key role to play in advancing the sustainable development goals," added Ms Carlsson.( With inputs from IANS )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Marathi Language Controversy

Maharashtra News

Mumbai Local

Weather Update

Mumbai Rains

Ahmedabad Plane Crash

BioconFOLLOW

Biocon, Latest News

Business :True North to invest Rs 536 crore in Biocon Biologics for 2.4 pc stake

Biopharmaceuticals major Biocon said on Monday the board of its subsidiary Biocon Biologics has approved a primary equity investment by True North which will invest Rs 536.25 crore to pick 2.44 per cent minority stake in the biosimilars business. ...

Business :True North to acquire 2.4% stake in Biocon arm

Pharmaceuticals major Biocon Ltd on Monday said that its subsidiary Biocon Biologics India has approved the acquisition of 2.44 per cent stake in it by private equity firm True North with an investment of Rs 536.25 crore. ...

National :Biocon cuts insulin price 50% in 'poor' countries

Biocon Biologics reduced the retail price of its recombinant human insulin 50 per cent in the low-and-middle income countries, the biotech major said on Friday. ...